FLGTNasdaq United States
Market cap
$526.643 M
$19.14 +3.18%
Close of 7 Aug 2026
Revenue
$322.7M
#2108 by revenue
Earnings
-$60.5M
Loss-making
Shares outstanding
27,515,293
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Fulgent Genetics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.